Leadership
José has more than 20 years of experience in finance, acquired both at large, multifaceted corporations such as Dell and ev3 (acquired by Covidien), and at medical device and biotech start-ups. He has a successful track record in initiating and leading large financial transactions, including orchestrating the acquisition of Vexim by Stryker.
Arnaud launched his career as a financial auditor at Ernst & Young. He then began a 20-year career at Stryker, where he held supply chain and operations management roles, particularly in support of the Spine division. During his last eight years at Stryker, he was responsible for the Spine division’s European manufacturing facilities, with a focus on improving operational efficiency and reducing manufacturing costs while putting customers first. Arnaud leads our operational activities, including R&D, quality department, regulatory affairs, and supply chain.
Georges brings over 20+ years of MedTech leadership across global corporations, with deep expertise in international healthcare markets and Ultrasound developed through senior roles at leading industry innovators, including Philips.
A visionary and execution‑driven leader, he has revitalized portfolios, led digital and AI‑enabled transformations, and built high‑performing cross‑functional teams.
At Germitec, Georges leads International Strategy and Commercial Operations across all regions and distributors outside North America. He drives market insights, segment‑focused go‑to‑market strategies, and customer engagement and commercial performance to expand automated UV‑C High‑Level Disinfection adoption and accelerate global growth.
Keith brings over 30 years of experience in the North American MedTech industry, including leadership roles at GE Healthcare and Nanosonics. Most recently, Koby was instrumental in growing HeraMED’s business in the US, optimizing its go-to-market strategy and overseeing the largest deployment of their FDA-approved telehealth solution. Keith leads the company’s entry into the US High-Level Disinfection market for ultrasound probes and its long-term commercial development.



